However, specific neurofilament patterns, such as elevated NfH in ALS and increased NfM in AD, may still aid in distinguishing between disease subtypes, suggesting potential value for targeted clinical applications despite the lack of overall diagnostic improvement from combining markers. The gene discussed is NEFH; the disease is amyotrophic lateral sclerosis.